(+)-catechin multiple interactions ISO RGD:731328 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of IP6K2 mRNA CTD PMID:24763279 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:731328 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of IP6K2 mRNA CTD PMID:22079256 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane decreases expression ISO RGD:1550594 6480464 2 more ... CTD PMID:25575267 1,2-dimethylhydrazine decreases expression ISO RGD:1550594 6480464 1, 2-Dimethylhydrazine results in decreased expression of IP6K2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1550594 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IP6K2 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:731328 6480464 Estradiol results in decreased expression of IP6K2 mRNA CTD PMID:23019147 , PMID:31614463 17beta-estradiol decreases expression ISO RGD:1550594 6480464 Estradiol results in decreased expression of IP6K2 mRNA CTD PMID:25575267 17beta-estradiol affects expression ISO RGD:731328 6480464 Estradiol affects the expression of IP6K2 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IP6K2 mRNA CTD PMID:21215274 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IP6K2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731328 6480464 Tetrachlorodibenzodioxin affects the expression of IP6K2 mRNA CTD PMID:22574217 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of IP6K2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of IP6K2 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:731328 6480464 beta-methylcholine affects the expression of IP6K2 mRNA CTD PMID:21179406 4,4'-sulfonyldiphenol increases methylation ISO RGD:731328 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of IP6K2 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO RGD:1550594 6480464 Fenretinide results in increased expression of IP6K2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of IP6K2 mRNA CTD PMID:25825206 acrylamide increases expression ISO RGD:731328 6480464 Acrylamide results in increased expression of IP6K2 mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO RGD:731328 6480464 Aflatoxin B1 results in decreased methylation of IP6K2 gene CTD PMID:27153756 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IP6K2 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:731328 6480464 Antirheumatic Agents results in increased expression of IP6K2 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:731328 6480464 aristolochic acid I results in increased expression of IP6K2 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:731328 6480464 Arsenic affects the methylation of IP6K2 gene CTD PMID:25304211 arsane increases expression ISO RGD:731328 6480464 Arsenic results in increased expression of IP6K2 mRNA CTD PMID:31739468 arsane multiple interactions ISO RGD:731328 6480464 [Arsenic co-treated with Iron] results in increased expression of IP6K2 mRNA CTD PMID:31739468 arsenic atom affects methylation ISO RGD:731328 6480464 Arsenic affects the methylation of IP6K2 gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:731328 6480464 [Arsenic co-treated with Iron] results in increased expression of IP6K2 mRNA CTD PMID:31739468 arsenic atom increases expression ISO RGD:731328 6480464 Arsenic results in increased expression of IP6K2 mRNA CTD PMID:31739468 benzo[a]pyrene decreases expression ISO RGD:1550594 6480464 Benzo(a)pyrene results in decreased expression of IP6K2 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I increases expression ISO RGD:731328 6480464 7 more ... CTD PMID:19150397 bisphenol A decreases expression ISO RGD:1550594 6480464 bisphenol A results in decreased expression of IP6K2 mRNA CTD PMID:25575267 bisphenol A increases expression ISO RGD:1550594 6480464 bisphenol A results in increased expression of IP6K2 mRNA CTD PMID:33221593 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of IP6K2 mRNA CTD PMID:30816183 more ... bisphenol A affects expression ISO RGD:731328 6480464 bisphenol A affects the expression of IP6K2 mRNA CTD PMID:30903817 bisphenol A decreases methylation ISO RGD:1550594 6480464 bisphenol A results in decreased methylation of IP6K2 promoter CTD PMID:27312807 bromobenzene affects expression EXP 6480464 bromobenzene affects the expression of IP6K2 mRNA CTD PMID:32479839 ciguatoxin CTX1B affects expression ISO RGD:1550594 6480464 Ciguatoxins affects the expression of IP6K2 mRNA CTD PMID:18353800 cobalt dichloride increases expression ISO RGD:731328 6480464 cobaltous chloride results in increased expression of IP6K2 mRNA CTD PMID:19320972 copper(II) sulfate increases expression ISO RGD:731328 6480464 Copper Sulfate results in increased expression of IP6K2 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:731328 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IP6K2 mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:731328 6480464 Coumestrol results in decreased expression of IP6K2 mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:1550594 6480464 Asbestos, Crocidolite results in decreased expression of IP6K2 mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:731328 6480464 Cyclosporine results in decreased expression of IP6K2 mRNA CTD PMID:27989131 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of IP6K2 mRNA CTD PMID:21266533 diethylstilbestrol decreases expression ISO RGD:1550594 6480464 Diethylstilbestrol results in decreased expression of IP6K2 mRNA CTD PMID:25575267 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of IP6K2 mRNA CTD PMID:29391264 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of IP6K2 mRNA CTD PMID:31464424 Enterolactone multiple interactions ISO RGD:731328 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IP6K2 mRNA CTD PMID:19167446 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of IP6K2 mRNA CTD PMID:24412560 estriol decreases expression ISO RGD:1550594 6480464 Estriol results in decreased expression of IP6K2 mRNA CTD PMID:25575267 ethanol affects splicing ISO RGD:1550594 6480464 Ethanol affects the splicing of IP6K2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:731328 6480464 Ethyl Methanesulfonate results in increased expression of IP6K2 mRNA CTD PMID:23649840 fenthion increases expression ISO RGD:1550594 6480464 Fenthion results in increased expression of IP6K2 mRNA CTD PMID:34813904 folic acid multiple interactions ISO RGD:1550594 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IP6K2 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:731328 6480464 Formaldehyde results in increased expression of IP6K2 mRNA CTD PMID:23649840 gallic acid increases expression ISO RGD:731328 6480464 Gallic Acid results in increased expression of IP6K2 mRNA CTD PMID:34408198 iron atom multiple interactions ISO RGD:731328 6480464 [Arsenic co-treated with Iron] results in increased expression of IP6K2 mRNA CTD PMID:31739468 iron(0) multiple interactions ISO RGD:731328 6480464 [Arsenic co-treated with Iron] results in increased expression of IP6K2 mRNA CTD PMID:31739468 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of IP6K2 mRNA CTD PMID:24136188 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of IP6K2 mRNA CTD PMID:24136188 methidathion increases expression ISO RGD:1550594 6480464 methidathion results in increased expression of IP6K2 mRNA CTD PMID:34813904 methyl methanesulfonate increases expression ISO RGD:731328 6480464 Methyl Methanesulfonate results in increased expression of IP6K2 mRNA CTD PMID:23649840 Methylazoxymethanol acetate decreases expression EXP 6480464 Methylazoxymethanol Acetate results in decreased expression of IP6K2 mRNA CTD PMID:28349193 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of IP6K2 mRNA CTD PMID:20360939 N-nitrosodiethylamine multiple interactions EXP 6480464 caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of IP6K2 mRNA] CTD PMID:20360939 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of IP6K2 mRNA CTD PMID:23665939 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of IP6K2 mRNA CTD PMID:23439660 paracetamol affects expression ISO RGD:1550594 6480464 Acetaminophen affects the expression of IP6K2 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of IP6K2 mRNA CTD PMID:33387578 phenethyl caffeate multiple interactions EXP 6480464 caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of IP6K2 mRNA] CTD PMID:20360939 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of IP6K2 mRNA CTD PMID:31324951 phenobarbital affects expression ISO RGD:1550594 6480464 Phenobarbital affects the expression of IP6K2 mRNA CTD PMID:23091169 pirinixic acid increases expression ISO RGD:1550594 6480464 pirinixic acid results in increased expression of IP6K2 mRNA CTD PMID:18301758 , PMID:23811191 potassium chromate increases expression ISO RGD:731328 6480464 potassium chromate(VI) results in increased expression of IP6K2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:731328 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of IP6K2 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1550594 6480464 Pregnenolone Carbonitrile results in increased expression of IP6K2 mRNA CTD PMID:28903501 quercetin increases expression ISO RGD:731328 6480464 Quercetin results in increased expression of IP6K2 mRNA CTD PMID:21632981 ritodrine increases expression ISO RGD:1550594 6480464 Ritodrine results in increased expression of IP6K2 mRNA CTD PMID:23370008 silicon dioxide increases expression ISO RGD:731328 6480464 Silicon Dioxide results in increased expression of IP6K2 mRNA CTD PMID:25351596 silver atom increases expression ISO RGD:731328 6480464 Silver results in increased expression of IP6K2 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:731328 6480464 Silver results in increased expression of IP6K2 mRNA CTD PMID:26014281 Soman increases expression EXP 6480464 Soman results in increased expression of IP6K2 mRNA CTD PMID:19281266 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of IP6K2 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1550594 6480464 Carbon Tetrachloride results in increased expression of IP6K2 mRNA CTD PMID:31919559 triptonide decreases expression ISO RGD:1550594 6480464 triptonide results in decreased expression of IP6K2 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1550594 6480464 troglitazone results in decreased expression of IP6K2 mRNA CTD PMID:28973697 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of IP6K2 mRNA CTD PMID:24136188 urethane increases expression ISO RGD:731328 6480464 Urethane results in increased expression of IP6K2 mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of IP6K2 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:731328 6480464 Valproic Acid results in decreased expression of IP6K2 mRNA CTD PMID:23179753 , PMID:28001369 valproic acid affects expression ISO RGD:731328 6480464 Valproic Acid affects the expression of IP6K2 mRNA CTD PMID:25979313 valproic acid decreases methylation ISO RGD:731328 6480464 Valproic Acid results in decreased methylation of IP6K2 gene CTD PMID:29154799 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of IP6K2 mRNA CTD PMID:23034163 zinc atom multiple interactions ISO RGD:731328 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of IP6K2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:731328 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of IP6K2 mRNA CTD PMID:18593933